REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F957. A total of 7 filers reported holding REGENERON PHARMACEUTICALS in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $8,119 | +119.6% | 11,300 | +151.1% | 0.08% | +68.9% |
Q1 2023 | $3,697 | -99.1% | 4,500 | +542.9% | 0.04% | +800.0% |
Q2 2022 | $413,000 | -73.7% | 700 | -73.1% | 0.01% | -50.0% |
Q3 2021 | $1,573,000 | -51.8% | 2,600 | -62.3% | 0.01% | -69.7% |
Q1 2021 | $3,264,000 | +71.5% | 6,900 | +102.9% | 0.03% | -40.0% |
Q3 2020 | $1,903,000 | +88.4% | 3,400 | +36.0% | 0.06% | -65.0% |
Q3 2018 | $1,010,000 | – | 2,500 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Graticule Asia Macro Advisors LLC | 24,000 | $11,787,000 | 0.56% |
Timber Hill LLC | 9,800 | $4,813,000 | 0.18% |
SIMPLEX TRADING, LLC | 1,126 | $1,997,000 | 0.09% |
Allianz Asset Management GmbH | 154,600 | $75,930,000 | 0.07% |
JPMORGAN CHASE & CO | 31,100 | $15,274,000 | 0.00% |